These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32456134)

  • 1. Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer.
    Grbčić P; Sedić M
    Molecules; 2020 May; 25(10):. PubMed ID: 32456134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Sphingosine Kinase 2 Inhibitor ABC294640 Restores the Sensitivity of BRAFV600E Mutant Colon Cancer Cells to Vemurafenib by Reducing AKT-Mediated Expression of Nucleophosmin and Translationally-Controlled Tumour Protein.
    Grbčić P; Eichmann TO; Kraljević Pavelić S; Sedić M
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
    Selvam SP; Ogretmen B
    Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting sphingosine-1-phosphate signaling for cancer therapy.
    Xie Z; Liu H; Geng M
    Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased S1P induces S1PR2 internalization to blunt the sensitivity of colorectal cancer to 5-fluorouracil via promoting intracellular uracil generation.
    Zhang YH; Cui SX; Wan SB; Wu SH; Qu XJ
    Acta Pharmacol Sin; 2021 Mar; 42(3):460-469. PubMed ID: 32647340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
    Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
    Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.
    Degagné E; Pandurangan A; Bandhuvula P; Kumar A; Eltanawy A; Zhang M; Yoshinaga Y; Nefedov M; de Jong PJ; Fong LG; Young SG; Bittman R; Ahmedi Y; Saba JD
    J Clin Invest; 2014 Dec; 124(12):5368-84. PubMed ID: 25347472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again.
    Oskouian B; Saba J
    Cell Cycle; 2007 Mar; 6(5):522-7. PubMed ID: 17361098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease.
    Wollny T; Wątek M; Durnaś B; Niemirowicz K; Piktel E; Żendzian-Piotrowska M; Góźdź S; Bucki R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S1P metabolism in cancer and other pathological conditions.
    Leong WI; Saba JD
    Biochimie; 2010 Jun; 92(6):716-23. PubMed ID: 20167244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling.
    Maceyka M; Milstien S; Spiegel S
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S272-6. PubMed ID: 18987387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting sphingosine-1-phosphate receptors in cancer.
    Watters RJ; Wang HG; Sung SS; Loughran TP; Liu X
    Anticancer Agents Med Chem; 2011 Nov; 11(9):810-7. PubMed ID: 21707490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The drug development based on sphingosine-1-phosphate signaling pathway].
    Bai J; Hu JP
    Yao Xue Xue Bao; 2016 Dec; 51(12):1822-8. PubMed ID: 29908533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
    Coant N; García-Barros M; Zhang Q; Obeid LM; Hannun YA
    Oncogene; 2018 Jul; 37(28):3852-3863. PubMed ID: 29662189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
    Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
    Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid metabolism in cancer signalling and therapy.
    Ogretmen B
    Nat Rev Cancer; 2018 Jan; 18(1):33-50. PubMed ID: 29147025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids.
    Uranbileg B; Kurano M; Kano K; Sakai E; Arita J; Hasegawa K; Nishikawa T; Ishihara S; Yamashita H; Seto Y; Ikeda H; Aoki J; Yatomi Y
    Clin Transl Med; 2022 Sep; 12(9):e1056. PubMed ID: 36125914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence Suggests Sphingosine 1-Phosphate Might Be Actively Generated, Degraded, and Transported to Extracellular Spaces With Increased S1P
    Uranbileg B; Nishikawa T; Ikeda H; Kurano M; Sato M; Saigusa D; Aoki J; Watanabe T; Yatomi Y
    Clin Colorectal Cancer; 2018 Jun; 17(2):e171-e182. PubMed ID: 29223361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon Cancer and Perturbations of the Sphingolipid Metabolism.
    Machala M; Procházková J; Hofmanová J; Králiková L; Slavík J; Tylichová Z; Ovesná P; Kozubík A; Vondráček J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.